Advanced Search

 

Study ID Status Title Patient Level Data
49653/028 Completed Bioequivalence Study of the Final Market Formulation of BRL 49653C Compared to the Clinical Trials Formulation
49653/029 Completed Evaluation of the Safety, Tolerability and Preliminary Pharmacokinetics of Single Rising Intravenous Doses of BRL 49653C in Normal Volunteers
49653/030 Completed A Bioequivalence Study of BRL 49653C Proposed Final Market Tablet Formulation (formula AGAA) versus BRL 49653C Clinical Trials Capsule Formulation (formula AB-AA)
49653/031 Completed An Investigation of the Effect of BRL 49653C on the Safety, Tolerability and Pharmacokinetics of Oral Contraceptives in Healthy Female Volunteers
49653/033 Completed Placebo controlled, double-blind, trial to study the effect of 12 week treatment with BRL-49653C on glucose and insulin metabolism in obese patients with NIDDM
49653/034 Completed A Study to Assess the Effects of BRL 49653C on the Pharmacokinetics of Digoxin in Healthy Adult Males
49653/035 Completed A Study to Assess The Effect of BRL 49653C on the Anticoagulant Effect of Warfarin in Healthy Male Volunteers
49653/036 Completed A Study to Determine the Effect of BRL 49653C on the Pharmacokinetics of Metformin in Healthy Male Volunteers
49653/037 Completed A Study to Assess the Effect of Ranitidine on the Bioavailability of BRL 49653C in Healthy Adult Males
49653/038 Completed An Evaluation of the Pharmacokinetics of a Single Oral Dose of BRL 49653C in Patients with Varying Degrees of Renal Insufficiency Compared to Volunteers with Normal Renal Function
49653/039 Completed An Investigation of the Effect of BRL 49653C on the Safety, Tolerability and Pharmacokinetics of Nifedipine in Healthy Volunteers
49653/040 Completed Effect of Acarbose on the Pharmacokinetics of BRL 49653C in Healthy Adult Volunteers
49653/041 Completed A Study to Evaluate the Effect of Ethanol Administration on the Pharmacodynamics of BRL 49653C in Chronically-Treated Type 2 Diabetic Patients
49653/043 Completed Placebo-controlled, Double-Blinded Trial to Study the Absorptive and Post-Absorptive Skeletal Muscle and Hepatic Metabolic Effects of BRL-49653C After 12 weeks Treatment in Patients with Non-Insulin Dependent Diabetes Mellitus
49653/044 Completed A 26-week Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of BRL 49653C When Administered Twice Daily to Patients with Non-Insulin Dependent Diabetes Mellitus (NIDDM) Who Are Inadequately…
49653/048 Completed A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients with Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
49653/049 Completed A Study to Determine the Balance/Excretion, Pharmacokinetics and Biotransformation of BRL 49653 Given as a Single Oral (8 mg pfb) and Single Intravenous (2 mg pfb) Doses of [14C]-BRL 49653C to Healthy Male Adult Volunteers and Determine the Pharmacokinetics of a Single Oral Dose (2 x 4 mg Tablet ...
49653/050 Completed A Clinical Evaluation of BRL49653C in Type-2 Diabetes Mellitus; An Early Phase II Open-label Study (Monotherapy)
49653/051 Completed A Clinical Evaluation of BRL49653C in Non-insulin-dependent Diabetes Mellitus.
49653/054 Completed Clinical Evaluation of BRL49653C in Type-2 Diabetes Mellitus (Monotherapy) - Double-blind Dose-finding Study.
49653/055 Completed Clinical Evaluation of BRL49653C in Type-2 Diabetes Mellitus (Combination Therapy with Sulphonylurea) - Double-blind Dose-finding Study.
49653/078 Completed A Placebo-controlled Study to Evaluate the Effect of Rosiglitazone on Plasma Volume and Red Blood Cell Volume in Healthy Volunteers
49653/079 Completed A 26-week Randomized, Double-Blind, Double-Dummy, Multicentered Study to Evaluate the Efficacy, Safety and Tolerability of Rosiglitazone when Administered to Patients with Non-Insulin Dependent Diabetes Mellitus (NIDDM) who are Inadequately Controlled on a Maximal Dose (20 mg/day) of Glyburide. Study Listed on ClinicalStudyDataRequest.com
49653/080 Completed A 3 Year Open-label, Multicenter, Active (Glyburide) Comparison Study to Evaluate the Effect of Rosiglitazone on Cardiovascular Function in Patients with Non-insulin Dependent Diabetes Mellitus (NIDDM)
49653/082 Completed A 26-Week Randomized, Double-Blind, Multicenter Study to Evaluate the Safety, Efficacy, and Tolerability of BRL 49653C when Administered Twice Daily to Patients with Non-Insulin Dependent Diabetes Mellitus (NIDDM) who are Inadequately Controlled on Insulin Monotherapy Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.